中西医结合治疗腹泻型肠易激综合征的临床研究

Abstract
Figure/Table
References (16)
Related Citation (5)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo explore the clinic effect of treatment on diarrhea-predominant irritable bowel syndrome(IBS) by using integrated Traditional Chinese Medicine and Western Medicine Therapy.Methods60 cases of IBS-D patients with syndrome of splenic asthenia and accumulation of dampness from Janury 2014 to December 2015 were selected, which were randomly divided into treatment group and control group,30 cases in each groups.Patients of treatment group were given Shenling Baishu Power and Institute for treatment.patients of control group were given Bifido for treatment,after 28 days,the clinical curative effectwere observated.ResultsThe symptoms scores of both the two groups after treatmentwere obviously lower than the before,the differenceswere significant(P＜0.05).After treatment,the symptoms score of the treatment group was significantly lower than that of the control group,the difference was significant(P＜0.05).The TCM symptoms curative effectof treatmentgroup was better than that of control group,after treatment,the difference was significant(P＜0.05).The total efficiency of the treatment group was 86.67%,which was higher than that of control group with 73.33%,the difference was significant(P＜0.05).No obvious adverse reaction occurred in the research.ConclusionThe therapy of combination shenling baizhu powderwith bifid triple viable capsules can obviously improve global symptoms of IBS-D,which iswith no side effect.

Key words： Diarrhea irritable bowel syndrome Shenling Baizhu Powder Bifido Therapy of combination of Chinese Traditional and Western Medicine

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SUN Zhao-shuang
	SUN Dan-dan

Cite this article:

SUN Zhao-shuang,SUN Dan-dan. A clinic study of treatment on diarrhea-predom inant irritable bowel syndrome by using integrated Traditional Chinese Medicine and W estern Medicine Therapy[J]. 中国当代医药, 2016, 23(34): 136-138.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I34/136

[1]	中华医学会消化病学分会，中国肠易激综合征专家共识意见（2015年，上海）[J].中华消化杂志，2016，36，（5）：299-312.
[2]	黄勇.肠胃舒方联全西药治疗腹泻型肠易激综合征的临床效果[J].中国当代医药，2014，21（23）：90-91.
[3]	葛均波，徐永健.内科学[M].8版.北京：人民卫生出版社，2013：399-401.
[4]	陈寒昱，孙志广.肠易激综合征发病机制研究进展[J].东南大学学报（医学版），2012，31（2）：243-245.
[5]	中国中西医结合学会消化系统疾病专业委员会，肠易激综合征中西医结合诊疗共识意见（2010年，苏州）[J].中国中西医结合杂志，2011，31（5）：587-590.
[6]	褚凡凡.腹泻型肠易激综合征发病机制及治疗现状[J].西部中医药，2013，26（10）：139-141.
[7]	高春波.参苓白术散加艾灸治疗腹泻型肠易激综合征的临床观察[J].陕西中医，2016，37（8）：944-945.
[8]	邹百柱.参苓白术散和半夏泻心汤治疗腹泻型肠易激综合征临床观察[J].中医药导报，2011，17（7）：116-117.
[9]	中华中医药学会脾胃病分会，肠易激综合征中医诊疗共识意见[J].中华中医药杂志，2010，25（7）：1062-1065.
[10]	郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：139-143.
[11]	褚娟红.参苓四逆汤治疗腹泻型肠易激综合征54例[J].浙江中医杂志，2016，51（8）：574-575.
[12]	张声生，汪红兵，李振华，等.360例腹泻型肠易激综合征的聚类分析及证候特征研究[J].中华中医药杂志，2010，25（8）：1183-1187.
[13]	吴勉华，王新月.中医内科学[M].9版.北京：中国医药科技出版社，2012：229-236.
[14]	姚莉，付玲，赵生俊.国内益生菌制剂治疗肠易激综合征临床疗效的Meta分析[J].中国循证医学杂志，2012，12（5）：602-607.
[15]	黄培宁，邓有辉.微生态制剂对慢性肝衰竭患者肠道菌群、血浆内毒素及细胞因子的影响[J].中华医院感染学杂志，2011，21（18）：3798-3800．
[16]	丁忠洋.参白术散加味对腹泻型肠易激综合征（脾虚湿盛）患者T淋巴细胞亚群的影响[D].长春：长春中医药大学，2015：13-21.